Status:
RECRUITING
PV Loop & Coarctation Study
Lead Sponsor:
University of Minnesota
Conditions:
Coarctation of Aorta
Eligibility:
All Genders
6+ years
Brief Summary
Coarctation of the aorta accounts for 4-7% of all congenital heart disease. While stent therapy, when feasible, is the standard of care for coarctation, it may not completely improve the work (and aft...
Eligibility Criteria
Inclusion
- Children 6 years of age and older and adults of all races and both sexes referred for elective cardiac catheterization and stent therapy for coarctation
- Those who provide informed consent for study participant.
Exclusion
- Children who undergo other interventions in addition to the coarctation
- Children with single ventricle physiology.
- Renal impairment
- Participant unwilling to sign a consent form.
Key Trial Info
Start Date :
June 4 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05362721
Start Date
June 4 2019
End Date
December 31 2026
Last Update
March 24 2025
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Los Angeles
Los Angeles, California, United States, 90027
2
Children's Hospital of Boston
Boston, Massachusetts, United States, 02115
3
Helen DeVos Children's Hospital
Grand Rapids, Michigan, United States, 49503
4
University of Minnesota
Minneapolis, Minnesota, United States, 55455